Indication
Relative Bioavailability
3 clinical trials
4 products
Clinical trial
An Open-label, Balanced, Randomized, Two-period, Crossover, Single Dose Study to Compare the Bioavailability of PanCytoVir™ Oral Suspension (100mg/ml), in Healthy, Adult, Human Subjects Under Fed and Fasting ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Product
PanCytoVir™Clinical trial
A Single Dose Oral Bioavailability Study of PanCytoVir™ Oral Suspension (100 mg/ml) 1000 mg Versus Probenecid 500 mg Tablets, 1000 mg (2 X 500 mg) in Healthy, Adult, Human Subjects Under Fasting ConditionsStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Product
PanCytoVirProduct
ProbenecidClinical trial
Relative Bioavailability of Tebipenem (SPR994) Crushed Tablet Formulation Administered by Nasogastric Tube in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-06-01
Product
Tebipenem